Exact Mass: 432.0087436

Exact Mass Matches: 432.0087436

Found 65 metabolites which its exact mass value is equals to given mass value 432.0087436, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

lamotrigine-2-N-glucuronide

3,5-diamino-2-[(2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]-6-(2,3-dichlorophenyl)-1,2lambda5,4-triazin-2-ylium

C15H16Cl2N5O6 (432.0477596)

lamotrigine-2-N-glucuronide is a metabolite of lamotrigine. Lamotrigine, marketed in the US and most of Europe as Lamictal by GlaxoSmithKline, is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is also used as an adjunct in treating depression, though this is considered off-label usage. For epilepsy, it is used to treat focal seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. (Wikipedia)

5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine

C18H20Cl4N4 (432.04420000000005)

Clometocillin

chlomethocillin

C17H18Cl2N2O5S (432.03134380000006)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

Isopropyltriphenylphosphonium iodide

C21H22IP (432.0503812)

Plumbane,dichlorodiphenyl-

C12H10Cl2Pb (431.99259300000006)

DIMETHYL 2-(3-BROMO-5-FORMYL-4-((2-METHOXYETHOXY)METHOXY)PHENYL)SUCCINATE

C17H21BrO8 (432.0419726)

Disperse Brown 1

C16H15Cl3N4O4 (432.015884)

demephion

C10H26O6P2S4 (432.0087436)

9-Bromo-10-(9-phenanthryl)anthracene

C28H17Br (432.0513542)

Tributyl(iodomethyl)stannane

C13H29ISn (432.0335894)

BCIP

C15H15BrClN2O4P (431.96412900000007)

4-(3-Bromo-2-thienyl)-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3 -b]pyridine

C18H13BrN2O2S2 (431.9601778)

3-IODO-N-(2-MORPHOLIN-4-YL-ETHYL)-BENZENESULFONAMIDE HYDROCHLORIDE

C12H18ClIN2O3S (431.97713780000004)

Pentaerythritol tetrakis(2-mercaptoacetate)

C13H20O8S4 (432.0041)

1,3-bis(3,5-dicarboxyphenyl)imidazoliumchloride

C19H13ClN2O8 (432.0360408)

Padsevonil

C14H14ClF5N4O2S (432.0446114)

C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

Lamotrigine N2-glucuronide

Lamotrigine N2-Glucuronide 85

C15H16Cl2N5O6+ (432.0477596)

Pamoic acid disodium

C23H14Na2O6 (432.0585744)

Pamoic acid disodium is a potent GPR35 agonist with an EC50 value of 79 nM. Pamoic acid disodium induces GPR35 internalization and activates ERK1/2 with EC50 values of 22 nM and 65 nM, respectively. Pamoic acid disodium potently recruits β-arrestin2 to GPR35 and has an antinociceptive effect[1].

Chloro(methyldiphenylphosphine)gold(I),95

C13H13AuClP (432.01089580000007)

3-Acetoxymercuri-4-aminobenzenesulfonamide

C8H10HgN2O4S (432.00675800000005)

D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

2-[5-[(3,4-Dichlorophenyl)methylthio]-4-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]pyridine

C19H14Cl2N4S2 (432.0036904)

N-(5-chloro-2-oxo-3-indolyl)-2-thiophen-2-yl-4-quinolinecarbohydrazide

C22H13ClN4O2S (432.04477080000004)

5-(4-Dibenzothiophenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine

C20H12N6S3 (432.0285552)

1-[[4-(6-Chloro-3-pyridinyl)phenyl]methyl]-5-(trifluoromethoxy)indole-2,3-dione

C21H12ClF3N2O3 (432.0488508000001)

2-[(4,6-dioxo-5-phenyl-1,4,5,6-tetrahydropyrimidin-2-yl)sulfanyl]-N-(4-sulfamoylphenyl)acetamide

C18H16N4O5S2 (432.0562086)

2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide

C12H12Cl3FN4O4S (431.96288540000006)

8-{(2E)-2-[(2Z)-2-bromo-3-phenylprop-2-en-1-ylidene]hydrazinyl}-6-hydroxy-7-(2-hydroxyethyl)-3-methyl-3,7-dihydro-2H-purin-2-one

C17H17BrN6O3 (432.0545432)

(2S,3S,4S,5R)-6-[3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16Cl2N5O6+ (432.0477596)

5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine

C18H20Cl4N4 (432.04420000000005)

2,6-Dichloro-2',3',5'-triacetyl-purine riboside

C15H14Cl2N4O7 (432.0239514)

2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

P2Y2R/GPR17 antagonist 1

C19H13ClN2O6S (432.01828280000007)

P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R and GPR17 antagonist with IC50 values of 3.17 μM and 1.67 μM against P2Y2R and GPR17, respectively. P2Y2R/GPR17 antagonist 1 shows excellent metabolic stability in human liver microsomes[1].

(5s,8r,9r)-9-(2,4-dibromo-5-methoxyphenyl)-8-hydroxy-7-methyl-1,7-diazaspiro[4.4]nonan-6-one

C15H18Br2N2O3 (431.9684078)

2-{[(5z)-5-{3-[(4-bromo-1h-pyrrol-2-yl)formamido]propylidene}-2-iminoimidazolidin-4-ylidene]amino}ethanesulfonic acid

C13H17BrN6O4S (432.02153020000003)

(1r,7s,8s,11r)-11-(hydroxymethyl)-17-methyl-10,16-dioxo-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-dien-7-yl acetate

C15H16N2O5S4 (431.9942046)

(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione

(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione

C19H16N2O6S2 (432.0449756)

1-{6,10,12-trichloro-3,13-dihydroxy-5,11-dimethoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}butan-1-one

C18H15Cl3O6 (431.993418)